Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Revue Neurologique
|
February 27, 2021
Is disease activity prior to fingolimod initiation predictive of response? Fingolimod as a "common" first line treatment
V Pantazou, R Du Pasquier, C Pot, et al.
Revue Neurologique
|
August 11, 2020
First-ever treatment in multiple sclerosis
V Pantazou, C Pot, R Du Pasquier, et al.
European Journal of Neurology
|
July 10, 2013
Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy
P Lozeron, M Théaudin, Z Mincheva, et al.
Journal of the Neurological Sciences
|
October 18, 2011
External carotid artery branches involvement in reversible cerebral vasoconstriction syndrome
E Melki, C Denier, M Théaudin-Saliou, et al.
Neuroradiology
|
June 27, 2012
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study
M Théaudin, G Saliou, B Ducot, et al.
Revue Neurologique
|
October 26, 2011
Short and long-term effect of IVIg in demyelinating neuropathy associated with MGUS, experience of a monocentric study
M Théaudin, P Lozeron, C Lacroix, et al.
Multiple Sclerosis and Related Disorders
|
May 31, 2022
Delayed and recurrent dimethyl fumarate induced-lymphopenia in patients with multiple sclerosis
S Borrelli, A Mathias, G Le Goff, et al.
Revue Neurologique
|
September 25, 2016
Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?
D Adams, G Beaudonnet, C Adam, et al.
Journal Francais D'Ophtalmologie
|
October 23, 2013
[Ocular involvement in familial amyloid polyneuropathy]
A Rousseau, G Kaswin, D Adams, et al.
European Journal of Neurology
|
October 24, 2018
Upper limb onset of hereditary transthyretin amyloidosis is common in non-endemic areas
M Théaudin, P Lozeron, V Algalarrondo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Revue Neurologique
|
February 27, 2021
Is disease activity prior to fingolimod initiation predictive of response? Fingolimod as a "common" first line treatment
V Pantazou, R Du Pasquier, C Pot, et al.
Revue Neurologique
|
August 11, 2020
First-ever treatment in multiple sclerosis
V Pantazou, C Pot, R Du Pasquier, et al.
European Journal of Neurology
|
July 10, 2013
Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy
P Lozeron, M Théaudin, Z Mincheva, et al.
Journal of the Neurological Sciences
|
October 18, 2011
External carotid artery branches involvement in reversible cerebral vasoconstriction syndrome
E Melki, C Denier, M Théaudin-Saliou, et al.
Neuroradiology
|
June 27, 2012
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study
M Théaudin, G Saliou, B Ducot, et al.
Revue Neurologique
|
October 26, 2011
Short and long-term effect of IVIg in demyelinating neuropathy associated with MGUS, experience of a monocentric study
M Théaudin, P Lozeron, C Lacroix, et al.
Multiple Sclerosis and Related Disorders
|
May 31, 2022
Delayed and recurrent dimethyl fumarate induced-lymphopenia in patients with multiple sclerosis
S Borrelli, A Mathias, G Le Goff, et al.
Revue Neurologique
|
September 25, 2016
Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?
D Adams, G Beaudonnet, C Adam, et al.
Journal Francais D'Ophtalmologie
|
October 23, 2013
[Ocular involvement in familial amyloid polyneuropathy]
A Rousseau, G Kaswin, D Adams, et al.
European Journal of Neurology
|
October 24, 2018
Upper limb onset of hereditary transthyretin amyloidosis is common in non-endemic areas
M Théaudin, P Lozeron, V Algalarrondo, et al.
Page
of 2